Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia

Abstract T-ALL relapses are characterized by chemotherapy resistance, cellular diversity and dismal outcome. To gain a deeper understanding of the mechanisms underlying relapses, we conduct single-cell RNA sequencing on 13 matched pediatric T-ALL patient-derived samples at diagnosis and relapse, alo...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia Costea, Kerstin K. Rauwolf, Pietro Zafferani, Tobias Rausch, Anna Mathioudaki, Judith Zaugg, Martin Schrappe, Cornelia Eckert, Gabriele Escherich, Jean P. Bourquin, Beat Bornhauser, Andreas E. Kulozik, Jan O. Korbel
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-61222-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839648074961518592
author Julia Costea
Kerstin K. Rauwolf
Pietro Zafferani
Tobias Rausch
Anna Mathioudaki
Judith Zaugg
Martin Schrappe
Cornelia Eckert
Gabriele Escherich
Jean P. Bourquin
Beat Bornhauser
Andreas E. Kulozik
Jan O. Korbel
author_facet Julia Costea
Kerstin K. Rauwolf
Pietro Zafferani
Tobias Rausch
Anna Mathioudaki
Judith Zaugg
Martin Schrappe
Cornelia Eckert
Gabriele Escherich
Jean P. Bourquin
Beat Bornhauser
Andreas E. Kulozik
Jan O. Korbel
author_sort Julia Costea
collection DOAJ
description Abstract T-ALL relapses are characterized by chemotherapy resistance, cellular diversity and dismal outcome. To gain a deeper understanding of the mechanisms underlying relapses, we conduct single-cell RNA sequencing on 13 matched pediatric T-ALL patient-derived samples at diagnosis and relapse, along with samples derived from 5 non-relapsing patients collected at diagnosis. This comprehensive longitudinal single-cell study in T-ALL reveals significant transcriptomic diversity. Notably, 11 out of 18 samples exhibit a subpopulation of T-ALL cells with stem-like features characterized by a common set of active regulons, expression patterns and splice isoforms. This subpopulation, accounting for a small proportion of leukemia cells at diagnosis, expands substantially at relapse, indicating resistance to therapy. Strikingly, increased stemness at diagnosis is associated with higher risk of treatment induction failure. Chemotherapy resistance is validated through in-vitro and in-vivo drug testing. Thus, we report the discovery of treatment-resistant stem-like cells in T-ALL, underscoring the potential for devising future therapeutic strategies targeting stemness-related pathways.
format Article
id doaj-art-cfd383dc119b4f36a259ffce4d4851a1
institution Matheson Library
issn 2041-1723
language English
publishDate 2025-06-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-cfd383dc119b4f36a259ffce4d4851a12025-06-29T11:13:04ZengNature PortfolioNature Communications2041-17232025-06-0116111410.1038/s41467-025-61222-1Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemiaJulia Costea0Kerstin K. Rauwolf1Pietro Zafferani2Tobias Rausch3Anna Mathioudaki4Judith Zaugg5Martin Schrappe6Cornelia Eckert7Gabriele Escherich8Jean P. Bourquin9Beat Bornhauser10Andreas E. Kulozik11Jan O. Korbel12Molecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of Heidelberg UniversityDivision of Pediatric Oncology, University Children’s HospitalEuropean Molecular Biology Laboratory (EMBL), Genome Biology UnitMolecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of Heidelberg UniversityMolecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of Heidelberg UniversityMolecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of Heidelberg UniversityDepartment of Pediatrics, University Hospital Schleswig-Holstein, Campus KielDepartment of Pediatric Oncology/Hematology, Charité Universitätsmedizin BerlinClinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-EppendorfDivision of Pediatric Oncology, University Children’s HospitalDivision of Pediatric Oncology, University Children’s HospitalMolecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of Heidelberg UniversityMolecular Medicine Partnership Unit (MMPU), EMBL and Medical Faculty of Heidelberg UniversityAbstract T-ALL relapses are characterized by chemotherapy resistance, cellular diversity and dismal outcome. To gain a deeper understanding of the mechanisms underlying relapses, we conduct single-cell RNA sequencing on 13 matched pediatric T-ALL patient-derived samples at diagnosis and relapse, along with samples derived from 5 non-relapsing patients collected at diagnosis. This comprehensive longitudinal single-cell study in T-ALL reveals significant transcriptomic diversity. Notably, 11 out of 18 samples exhibit a subpopulation of T-ALL cells with stem-like features characterized by a common set of active regulons, expression patterns and splice isoforms. This subpopulation, accounting for a small proportion of leukemia cells at diagnosis, expands substantially at relapse, indicating resistance to therapy. Strikingly, increased stemness at diagnosis is associated with higher risk of treatment induction failure. Chemotherapy resistance is validated through in-vitro and in-vivo drug testing. Thus, we report the discovery of treatment-resistant stem-like cells in T-ALL, underscoring the potential for devising future therapeutic strategies targeting stemness-related pathways.https://doi.org/10.1038/s41467-025-61222-1
spellingShingle Julia Costea
Kerstin K. Rauwolf
Pietro Zafferani
Tobias Rausch
Anna Mathioudaki
Judith Zaugg
Martin Schrappe
Cornelia Eckert
Gabriele Escherich
Jean P. Bourquin
Beat Bornhauser
Andreas E. Kulozik
Jan O. Korbel
Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia
Nature Communications
title Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia
title_full Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia
title_fullStr Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia
title_full_unstemmed Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia
title_short Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia
title_sort role of stem like cells in chemotherapy resistance and relapse in pediatric t cell acute lymphoblastic leukemia
url https://doi.org/10.1038/s41467-025-61222-1
work_keys_str_mv AT juliacostea roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT kerstinkrauwolf roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT pietrozafferani roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT tobiasrausch roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT annamathioudaki roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT judithzaugg roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT martinschrappe roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT corneliaeckert roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT gabrieleescherich roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT jeanpbourquin roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT beatbornhauser roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT andreasekulozik roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia
AT janokorbel roleofstemlikecellsinchemotherapyresistanceandrelapseinpediatrictcellacutelymphoblasticleukemia